Takeda announces positive data from three phase 3...
Category : Clinical Trial Update 1 October 2026Takeda announced new data from three phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279), an...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Tolerance Bio Licenses TLB-33 From Tanabe Pharma f...
Category : Clinical Trial Update 30 September 2026Agreement Gives Tolerance Bio Worldwide Development Rights Outside Japan Tolerance Bio, Inc. has...
Airway Therapeutics Receives $1.9 Million NIH Gran...
Category : Clinical Trial Update 30 September 2026Funding Will Support U.S. Clinical Development in Extremely Preterm Infants Airway Therapeutics,...
Vanda Reports Positive Phase III Results for HETLI...
Category : Clinical Trial Update 30 September 2026Phase III Study Meets Primary Endpoint in Adults With DSWPD Vanda Pharmaceuticals Inc. has report...
Johnson & Johnson Reports Positive Phase 4 STAR Re...
Category : Clinical Trial Update 29 September 2026Tremfya Meets Main Study Goals in Patients With Axial Involvement Johnson & Johnson has annou...
Latest Newsletter Post
-
Takeda announces positive data from..
1 October 2026
-
Vanda Reports Positive Phase III Re..
30 September 2026
-
Airway Therapeutics Receives $1.9 M..
30 September 2026
-
Tolerance Bio Licenses TLB-33 From..
30 September 2026
-
Ascletis Reports Positive Phase I R..
29 September 2026
